Annual CFO
-$48.94 M
-$10.93 M-28.75%
December 1, 2024
Summary
- As of February 24, 2025, RCEL annual cash flow from operations is -$48.94 million, with the most recent change of -$10.93 million (-28.75%) on December 1, 2024.
- During the last 3 years, RCEL annual CFO has fallen by -$43.44 million (-789.64%).
- RCEL annual CFO is now -789.64% below its all-time high of -$5.50 million, reached on December 1, 2021.
Performance
RCEL Cash From Operations Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly CFO
-$8.08 M
-$867.00 K-12.02%
December 1, 2024
Summary
- As of February 24, 2025, RCEL quarterly cash flow from operations is -$8.08 million, with the most recent change of -$867.00 thousand (-12.02%) on December 1, 2024.
- Over the past year, RCEL quarterly CFO has increased by +$2.78 million (+25.61%).
- RCEL quarterly CFO is now -1312.76% below its all-time high of -$572.00 thousand, reached on September 30, 2021.
Performance
RCEL Quarterly CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM CFO
-$48.94 M
+$2.78 M+5.38%
December 1, 2024
Summary
- As of February 24, 2025, RCEL TTM cash flow from operations is -$48.94 million, with the most recent change of +$2.78 million (+5.38%) on December 1, 2024.
- Over the past year, RCEL TTM CFO has dropped by -$10.93 million (-28.75%).
- RCEL TTM CFO is now -902.64% below its all-time high of -$4.88 million, reached on September 30, 2019.
Performance
RCEL TTM CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Cash From Operations Formula
CFO = Net Income + Non Cash Expenses + Changes In Working Capital
RCEL Cash From Operations Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -28.8% | +25.6% | -28.8% |
| 3 y3 years | -789.6% | +25.6% | -28.8% |
| 5 y5 years | -115.1% | +25.6% | -28.8% |
RCEL Cash From Operations Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -789.6% | at low | -1312.8% | +61.3% | -263.9% | +8.5% |
| 5 y | 5-year | -789.6% | at low | -1312.8% | +61.3% | -413.3% | +8.5% |
| alltime | all time | -789.6% | at low | -1312.8% | +61.3% | -902.6% | +8.5% |
AVITA Medical Cash From Operations History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2024 | -$48.94 M(+28.7%) | -$8.08 M(+12.0%) | -$48.94 M(-5.4%) |
| Sep 2024 | - | -$7.21 M(-43.6%) | -$51.72 M(-3.3%) |
| Jun 2024 | - | -$12.78 M(-38.7%) | -$53.48 M(+7.4%) |
| Mar 2024 | - | -$20.86 M(+92.1%) | -$49.80 M(+31.0%) |
| Dec 2023 | -$38.01 M(+99.1%) | -$10.86 M(+21.0%) | -$38.01 M(+24.3%) |
| Sep 2023 | - | -$8.97 M(-1.4%) | -$30.58 M(+25.4%) |
| Jun 2023 | - | -$9.10 M(+0.3%) | -$24.39 M(+29.8%) |
| Mar 2023 | - | -$9.07 M(+164.1%) | -$18.79 M(-1.6%) |
| Dec 2022 | -$19.09 M(+247.0%) | -$3.44 M(+23.7%) | -$19.09 M(+21.9%) |
| Sep 2022 | - | -$2.78 M(-20.8%) | -$15.65 M(+16.4%) |
| Jun 2022 | - | -$3.51 M(-62.6%) | -$13.45 M(-3.2%) |
| Mar 2022 | - | -$9.37 M(+1538.1%) | -$13.89 M(-25.9%) |
| Dec 2021 | -$5.50 M | - | - |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2021 | - | -$572.00 K(-85.5%) | -$18.76 M(-27.6%) |
| Jun 2021 | -$25.90 M(+13.9%) | -$3.95 M(-53.9%) | -$25.90 M(-7.1%) |
| Mar 2021 | - | -$8.56 M(+50.9%) | -$27.87 M(+4.8%) |
| Dec 2020 | - | -$5.67 M(-26.4%) | -$26.60 M(+4.0%) |
| Sep 2020 | - | -$7.71 M(+30.3%) | -$25.58 M(+12.4%) |
| Jun 2020 | -$22.75 M(+18.2%) | -$5.92 M(-18.9%) | -$22.75 M(+35.2%) |
| Mar 2020 | - | -$7.29 M(+56.8%) | -$16.83 M(+76.5%) |
| Dec 2019 | - | -$4.65 M(-4.7%) | -$9.53 M(+95.3%) |
| Sep 2019 | - | -$4.88 M | -$4.88 M |
| Jun 2019 | -$19.25 M(+48.5%) | - | - |
| Jun 2018 | -$12.96 M(+97.1%) | - | - |
| Jun 2017 | -$6.58 M(+10.9%) | - | - |
| Jun 2016 | -$5.93 M | - | - |
FAQ
- What is AVITA Medical annual cash flow from operations?
- What is the all time high annual CFO for AVITA Medical?
- What is AVITA Medical annual CFO year-on-year change?
- What is AVITA Medical quarterly cash flow from operations?
- What is the all time high quarterly CFO for AVITA Medical?
- What is AVITA Medical quarterly CFO year-on-year change?
- What is AVITA Medical TTM cash flow from operations?
- What is the all time high TTM CFO for AVITA Medical?
- What is AVITA Medical TTM CFO year-on-year change?
What is AVITA Medical annual cash flow from operations?
The current annual CFO of RCEL is -$48.94 M
What is the all time high annual CFO for AVITA Medical?
AVITA Medical all-time high annual cash flow from operations is -$5.50 M
What is AVITA Medical annual CFO year-on-year change?
Over the past year, RCEL annual cash flow from operations has changed by -$10.93 M (-28.75%)
What is AVITA Medical quarterly cash flow from operations?
The current quarterly CFO of RCEL is -$8.08 M
What is the all time high quarterly CFO for AVITA Medical?
AVITA Medical all-time high quarterly cash flow from operations is -$572.00 K
What is AVITA Medical quarterly CFO year-on-year change?
Over the past year, RCEL quarterly cash flow from operations has changed by +$2.78 M (+25.61%)
What is AVITA Medical TTM cash flow from operations?
The current TTM CFO of RCEL is -$48.94 M
What is the all time high TTM CFO for AVITA Medical?
AVITA Medical all-time high TTM cash flow from operations is -$4.88 M
What is AVITA Medical TTM CFO year-on-year change?
Over the past year, RCEL TTM cash flow from operations has changed by -$10.93 M (-28.75%)